ArticleJCO oncology practice2022

Growing Financial Burden From High-Cost Targeted Oral Anticancer Medicines Among Medicare Beneficiaries With Cancer.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.